Introduction

Aaron bower, one of the neuralogy residents here a on the aben hospital. The plan for to day is we're going to go through some of the major drug classes and drugs that we use in treatment management of parkinson's disease. Think some of the big boxes that will cover will obviously be some of our dophemine precursors, like cinnemet,. Then the dopheman receptor agonists, the m a o b inhibitors, the comt inhibitors as well; then a myriad of other agents, including some of the anti colenergics and newer medications that have come onto the market.